Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Bever

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Journal of Rehabilitation Research and Development|July 30, 2015
VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohortsWilliam J Culpepper, Mitchell T Wallin, Laurence S Magder, et al.
Journal of Neuroimmunology|August 21, 2012
Use of engineered bone marrow stem cells to deliver brain derived neurotrophic factor under the control of a tetracycline sensitive response element in experimental allergic encephalomyelitisTapas K Makar, Vamshi K C Nimmagadda, Gopi K Patibandla, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 22, 2010
Quality indicators for multiple sclerosisEric M Cheng, Carolyn J Crandall, Christopher T Bever, et al.
Journal of Neuroimmunology|March 6, 2016
TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosisTapas K Makar, Vamshi K C Nimmagadda, Ishwar S Singh, et al.
Neurology|May 25, 2007
Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology [RETIRED]J J Halperin, E D Shapiro, E Logigian, et al.
Neurology|April 1, 1986
Preliminary trial of poly ICLC in chronic progressive multiple sclerosisC T Bever, A M Salazar, E Neely, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2017
A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Short- and medium-term benefitsCinda L Hugos, Zunqiu Chen, Yiyi Chen, et al.
Scientific Reports|April 6, 2023
Immunomodulatory therapy with glatiramer acetate reduces endoplasmic reticulum stress and mitochondrial dysfunction in experimental autoimmune encephalomyelitisTapas K Makar, Poornachander R Guda, Sugata Ray, et al.
Neurology|June 1, 1994
The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trialC T Bever, D Young, P A Anderson, et al.
Archives of Physical Medicine and Rehabilitation|August 19, 2011
Effect of gravity on robot-assisted motor training after chronic stroke: a randomized trialSusan S Conroy, Jill Whitall, Laura Dipietro, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Journal of Rehabilitation Research and Development|July 30, 2015
VHA Multiple Sclerosis Surveillance Registry and its similarities to other contemporary multiple sclerosis cohortsWilliam J Culpepper, Mitchell T Wallin, Laurence S Magder, et al.
Journal of Neuroimmunology|August 21, 2012
Use of engineered bone marrow stem cells to deliver brain derived neurotrophic factor under the control of a tetracycline sensitive response element in experimental allergic encephalomyelitisTapas K Makar, Vamshi K C Nimmagadda, Gopi K Patibandla, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 22, 2010
Quality indicators for multiple sclerosisEric M Cheng, Carolyn J Crandall, Christopher T Bever, et al.
Journal of Neuroimmunology|March 6, 2016
TrkB agonist, 7,8-dihydroxyflavone, reduces the clinical and pathological severity of a murine model of multiple sclerosisTapas K Makar, Vamshi K C Nimmagadda, Ishwar S Singh, et al.
Neurology|May 25, 2007
Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology [RETIRED]J J Halperin, E D Shapiro, E Logigian, et al.
Neurology|April 1, 1986
Preliminary trial of poly ICLC in chronic progressive multiple sclerosisC T Bever, A M Salazar, E Neely, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 12, 2017
A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Short- and medium-term benefitsCinda L Hugos, Zunqiu Chen, Yiyi Chen, et al.
Scientific Reports|April 6, 2023
Immunomodulatory therapy with glatiramer acetate reduces endoplasmic reticulum stress and mitochondrial dysfunction in experimental autoimmune encephalomyelitisTapas K Makar, Poornachander R Guda, Sugata Ray, et al.
Neurology|June 1, 1994
The effects of 4-aminopyridine in multiple sclerosis patients: results of a randomized, placebo-controlled, double-blind, concentration-controlled, crossover trialC T Bever, D Young, P A Anderson, et al.
Archives of Physical Medicine and Rehabilitation|August 19, 2011
Effect of gravity on robot-assisted motor training after chronic stroke: a randomized trialSusan S Conroy, Jill Whitall, Laura Dipietro, et al.
Pageof 11